The life sciences are in the midst of a crucial shift, driven by the emergence of organoid-based models and the power of automation. Organoids—three-dimensional cell cultures that mimic human tissue ...

3D organoid models are becoming increasingly important in biological research and drug discovery. However, their use remains difficult to standardize because the workflow is complex, highly sensitive ...

Megan covers the intersection of science and society. How is biomedical research funded? Who benefits? And how do new technologies reflect and shape our values? You can reach Megan on Signal at ...

Organoid models, integrated with automation and AI, are reshaping preclinical drug development by producing more predictive, human-relevant data than traditional models. Regulatory reforms and ...

Neurological diseases like Alzheimer's and Parkinson's are a serious global health challenge. Despite enormous investment in drug discovery and development pipelines, progress has been hindered by ...